Skip to main content

Advertisement

Log in

Initial treatment of hypertension and adherence to therapy in general practice in Italy

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Background

Antihypertensive agents are among the most used therapeutic classes. The approach to the pharmacological treatment of hypertension is guided by international recommendations and adherence to treatment is known to result in effective prevention of cardiovascular risk.

Aim

The aim of this study was to evaluate the pattern of use of antihypertensive agents in general practice in terms of drug choice for the initial treatment of hypertension and adherence to treatments among newly recruited patients.

Methods

We collected the data of all antihypertensive drugs prescribed by general practitioners (GPs) and reimbursed between January 1998 and December 2002 by a Local Health Authority of Emilia Romagna (Ravenna district, 350,000 inhabitants). We selected subjects aged 40 years and older, permanently living in the area during the whole period of the study, who received their first prescription of antihypertensives between January and December 1999, with no prescription of antihypertensive agents in the previous year. For each patient, we documented the starting regimen and evaluated adherence to treatment in terms of persistence during the years (patients were defined persistent if they received at least one prescription per year) and in terms of daily coverage (patients were defined covered if they received an amount of drugs consistent with a daily treatment). Finally, switches or addition of other therapeutic classes during the 3-year period were identified.

Results

A cohort of 6,043 subjects receiving their first antihypertensive treatment in 1999 was obtained. Regarding the starting regimen, monotherapies with angiotensin converting enzyme inhibitors (n=1,597; 26%) or calcium channel blockers (n=1126; 19%) were the most frequently prescribed. Of the patients, 21% started with a drug combination regimen. Regarding adherence to treatment, 18% of the cohort received only one prescription throughout the 3 years, 13% received more than one prescription but stopped the therapy during the first year, 69% were persistent during the second year and 60% also during the third year. Only 34% were covered during the first year and 24% also during the second year, whereas only 20% of the patients resulted covered throughout the 3 years. Among persistent patients, 41% maintained the same antihypertensive regimen throughout the 3 years, 25% added other drugs to the initial treatment and 34% switched to completely different regimens.

Conclusions

Our findings reflect the lack of convergence among guidelines on the drug class(es) to be considered as first choice in the initial treatment of hypertension. Although an intervention in this field may have important implications in terms of cost savings, the ongoing debate does not allow us to draw definite conclusions on whether measures should be taken by the National Health Authority. However, the lack of adherence to antihypertensive treatment is undoubtedly a matter of concern for public health and should be addressed with appropriate interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Anonymous (2004) The use of drugs in Italy—National report 2003

  2. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F (1985) Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet 1:1349–1354

    PubMed  Google Scholar 

  3. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO (1991) Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 338:1281–1285

    PubMed  Google Scholar 

  4. Anonymous (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension detection and follow-up program cooperative group. JAMA 242:2562–2571

    PubMed  Google Scholar 

  5. Anonymous (1982) The effect of treatment on mortality in “mild” hypertension: results of the hypertension detection and follow-up program. N Engl J Med 307:976–980

    PubMed  Google Scholar 

  6. Anonymous (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). SHEP cooperative research group. JAMA 265:3255–3264

    PubMed  Google Scholar 

  7. Gueyffier F, Boutitie F, Boissel JP, Pocock S, Coope J, Cutler J, Ekbom T, Fagard R, Friedman L, Perry M, Prineas R, Schron E (1997) Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA investigators. Ann Intern Med 126:761–767

    PubMed  Google Scholar 

  8. Turnbull F (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomised trials. Lancet 362:1527–1535

    PubMed  Google Scholar 

  9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) In: 7th report of the joint national Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572

    PubMed  Google Scholar 

  10. August P (2003) Initial treatment of hypertension. N Engl J Med 348:610–617

    PubMed  Google Scholar 

  11. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Luscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A (2003) Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21:1779–1786

    PubMed  Google Scholar 

  12. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, Thom SM (2004) British hypertension society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 328:634–640

    PubMed  Google Scholar 

  13. Trilling JS, Froom J (2000) The urgent need to improve hypertension care. Arch Fam Med 9:794–801

    PubMed  Google Scholar 

  14. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP (1995) Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 311:293–295

    PubMed  Google Scholar 

  15. Casiglia E, Mazza A, Tikhonoff V, Pessina AC (2002) Population-based studies improve outcome in hypertensive patients. Am J Hypertens 15:605–608

    PubMed  Google Scholar 

  16. Mancia G, Pessina AC, Trimarco B, Grassi G (2004) Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens 22:2387–2396

    PubMed  Google Scholar 

  17. Montanaro N, Vaccheri A, Magrini N, Battilana M (1992) FARMAGUIDA: a databank for the analysis of the Italian drug market and drug utilization in general practice. Eur J Clin Pharmacol 42:395–399

    PubMed  Google Scholar 

  18. WHO Collaborating Centre for Drug Statistics Methodology (Norway) (2000) ATC index with DDDs

  19. Messerli FH (2000) Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and lipid-lowering treatment to prevent heart attack trial. Lancet 355:863–864

    PubMed  Google Scholar 

  20. Anonymous (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 288:2981–2997

    PubMed  Google Scholar 

  21. Motola D, Vaccheri A, Silvani MC, Poluzzi E, Bottoni A, De Ponti F, Montanaro N (2004) Pattern of NSAID use in the Italian general population: a questionnaire-based survey. Eur J Clin Pharmacol 60:731–738

    PubMed  Google Scholar 

  22. Bloom BS (1998) Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 20:671–681

    PubMed  Google Scholar 

  23. Marentette MA, Gerth WC, Billings DK, Zarnke KB (2002) Antihypertensive persistence and drug class. Can J Cardiol 18:649–656

    PubMed  Google Scholar 

  24. Degli Esposti L, Degli Esposti E, Valpiani G, Di Martino M, Saragoni S, Buda S, Baio G, Capone A, Sturani A (2002) A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther 24:1347–1357

    PubMed  Google Scholar 

  25. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP (1995) Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 311:293–295

    PubMed  Google Scholar 

  26. Caro JJ, Speckman JL, Salas M, Raggio G, Jackson JD (1999) Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ 160:41–46

    PubMed  Google Scholar 

  27. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD (1999) Persistence with treatment for hypertension in actual practice. CMAJ 160:31–37

    PubMed  Google Scholar 

  28. Payne KA, Esmonde-White S (2000) Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep 2:515–524

    PubMed  Google Scholar 

  29. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J (1997) The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 10:697–704

    PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank the Local Health Authority of Ravenna, for supplying prescribing data. The study was supported by grants from the Regione Emilia Romagna and the University of Bologna. An institutional unrestricted grant was also received by Roche S.p.A.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicola Montanaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poluzzi, E., Strahinja, P., Vargiu, A. et al. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 61, 603–609 (2005). https://doi.org/10.1007/s00228-005-0957-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-005-0957-y

Keywords

Navigation